Form 4: Arteris Inc. CFO Nicholas B. Hawkins Sells Shares Under 10b5-1 Trading Plan

Arteris Inc.'s CFO, Nicholas B. Hawkins, sold 4,560 shares of common stock at an average price of $12.3394 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, the VP and Chief Financial Officer of Arteris, Inc., executed a sale of company stock.
• The transaction involved the sale of 4,560 shares of common stock.
• The sale occurred on January 6, 2025.
• The average price per share was $12.3394.
• The shares were sold under a pre-arranged 10b5-1 trading plan adopted on May 20, 2024.
• The sale was executed in multiple transactions with prices ranging from $12.19 to $12.56.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of an insider stock sale under a pre-arranged trading plan, which is common practice for executives of publicly traded companies.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies to avoid accusations of insider trading.
• The sale of shares by a CFO is not unusual, and the disclosure is in line with SEC regulations.
• Comparable companies would also have similar disclosures when executives sell shares.

Stakeholder Impact

• The stock sale by the CFO may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's operations or financial health.

Key Dates

Keywords

Arteris Inc., Nicholas B. Hawkins, insider trading, 10b5-1 trading plan, stock sale, CFO, securities